EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

InvestmentUpdated on 5 December 2024

Xemperia seeding round

Sarah Cattin

CTO at Xemperia

Fribourg, Switzerland

About

At Xemperia, we are at the beginning of an exciting path: the validation of our amazing blood test to detect early breast cancer at large scale.

To continue, we are looking for trustful investors that would help us to achieve this stage of development, in view to impruve women life quality and survival !

For this next phase, we are currently in a seeding round, looking for 2mio CHF.

Stage

  • See stage.

Applies to

  • Biotech and Pharma
  • Healthcare

Attached files

Organisation

Xemperia

Startup

Fribourg, Switzerland